Early-onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD) or MEGF10 myopathy is associated with mutations in MEGF10, in which satellite cells from the patients show impaired proliferation and differentiation. The gene discussed is MEGF10; the disease is Areflexia.